VR Adviser

Venrock Adviser as of June 30, 2026

Portfolio Holdings for Venrock Adviser

Venrock Adviser holds 33 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apogee Therapeutics (APGE) 34.2 $1.1B 8.5M 132.73
Oruka Therapeutics (ORKA) 12.0 $395M 4.1M 95.17
Erasca (ERAS) 9.9 $328M 18M 18.32
Spyre Therapeutics Com New (SYRE) 8.0 $265M 3.0M 88.78
Dianthus Therapeutics (DNTH) 3.5 $115M 1.2M 97.48
Ocular Therapeutix (OCUL) 3.1 $102M 10M 9.82
Damora Therapeutics Com New (DMRA) 2.8 $94M 3.6M 26.01
Savara (SVRA) 2.8 $91M 15M 6.16
Jade Biosciences Com New (JBIO) 2.2 $72M 3.2M 22.22
Cogent Biosciences (COGT) 1.9 $64M 1.6M 38.70
Miragen Therapeutics (VRDN) 1.8 $60M 3.3M 18.37
Vor Biopharma Com New (VOR) 1.7 $56M 3.0M 18.41
Dyne Therapeutics (DYN) 1.5 $48M 2.2M 22.21
Maze Therapeatics (MAZE) 1.4 $48M 1.6M 29.84
Relmada Therapeutics (RLMD) 1.4 $47M 6.8M 6.92
Oric Pharmaceuticals (ORIC) 1.4 $47M 4.3M 10.83
Crescent Biopharma (CBIO) 1.2 $38M 2.1M 18.00
Zura Bio Class A Ord Shs (ZURA) 1.2 $38M 6.4M 5.90
Adlai Nortye Sponsored Ads (ANL) 1.1 $37M 3.2M 11.50
Enliven Therapeutics (ELVN) 0.8 $27M 526k 50.75
Cybin Com New (HELP) 0.8 $26M 3.9M 6.61
Cullinan Oncology (CGEM) 0.8 $25M 1.4M 18.21
Century Therapeutics (IPSC) 0.6 $21M 8.7M 2.45
Artiva Biotherapeutics (ARTV) 0.6 $20M 2.0M 9.70
Cytomx Therapeutics (CTMX) 0.6 $19M 5.0M 3.75
Achieve Life Sciences (ACHV) 0.5 $18M 2.8M 6.53
Parabilis Medicines 0.5 $17M 625k 27.37
Surrozen Com New (SRZN) 0.5 $16M 633k 25.95
Korro Bio (KRRO) 0.4 $13M 1.0M 13.18
Alto Neuroscience Com Shs (ANRO) 0.4 $13M 500k 26.39
X4 Pharmaceuticals Com New (XFOR) 0.3 $9.0M 1.9M 4.67
Research Alliance Corp Iii Ord Shs Cl A 0.1 $3.2M 300k 10.70
Inmed Pharmaceuticals Com New (INM) 0.0 $51k 33k 1.55